Podcasts about ncd

This is Nelson John, and I'll bring you the top business and tech stories, let's get started. US-China Tariff War Escalates The US-China trade tensions hit a boiling point as the White House confirmed a 104% tariff on Chinese imports, effective April 9. While President Trump says he's “waiting for China's call,” Beijing isn't backing down, calling the move “blackmail.” Global markets, oddly, bounced back slightly on hopes of negotiations—but signs of a resolution remain slim. Apple's Satcom Partner Eyes India Globalstar, the satellite partner behind Apple's emergency SOS feature, has applied to enter India's growing satellite market. With just 31 satellites compared to Starlink's 7,000+, Globalstar is eyeing a niche play. But competition is heating up, with players like Jio, OneWeb, and Amazon Kuiper racing for spectrum. India's satcom sector could grow nearly 10x by 2028. BoAt Sets Sail for IPO—Again India's popular wearables brand BoAt is gearing up for a ₹2,000 crore IPO. After shelving its 2022 plans, the company has confidentially filed papers under SEBI's revised norms. The issue includes a ₹900 crore fresh issue and ₹1,100 crore offer-for-sale. Proceeds will fund R&D, product upgrades, and debt reduction—potentially making this one of the year's most anticipated listings. India's Big Shipbuilding Ambition India is charting a new course in shipbuilding, teaming up with South Korea's Hyundai and Japan's Mitsui. Cochin Shipyard is close to sealing a deal for a new Kochi facility, with land provided by the government. The goal? Boost India's share in the $100 billion global shipbuilding market from less than 1% to a top-5 position by 2047, backed by a ₹25,000 crore Maritime Development Fund. Apollo Hospitals Bets Big on NCD Care Apollo Hospitals is investing ₹6,000 crore to expand its urban footprint and fight India's rising tide of non-communicable diseases (NCDs). The two-phase plan will add 3,500 beds across cities like Pune, Mumbai, and Chennai. Apollo's “Health of the Nation” report reveals 27% of 2.5 million screened individuals had multiple NCD risk factors. The healthcare giant is pushing for nationwide screening and preventive school health programs.

De Nederlandse Vereniging van Commissarissen en Directeuren (NCD) zet zich al jaren in voor het dichten van de loonkloof. Nu komt minister van Sociale Zaken Eddy van Hijum (NSC) met een wetsvoorstel dat werkgevers verplicht om gelijke beloning tussen mannen en vrouwen te garanderen. Kan dat de toefkaart voor NCD zijn? Macro met Boot Elke dag een intrigerende gedachtewisseling over de stand van de macro-economie. Op maandag en vrijdag gaat presentator Thomas van Zijl in gesprek met econoom Arnoud Boot, de rest van de week praat Van Zijl met econoom Edin Mujagić. economenpanel Moet de staatsschuld omhoog om te investeren in het verdienvermogen van Nederland? En: waarom wil Trump de de waarde van dollar verlagen? Dat en meer bespreken we om 11.30 in het economenpanel met: Barbara Baarsma, hoofdeconoom van PwC Nederland en hoogleraar marktwerking- en mededingingseconomie aan de UVA en Wimar Bolhuis, Directeur TNO Vector - Centrum voor Maatschappelijke Innovatie en Strategie, en docent Economie Universiteit Leiden. Luister l economenpanel Contact & Abonneren BNR Zakendoen zendt elke werkdag live uit van 11:00 tot 13:30 uur. Je kunt de redactie bereiken via e-mail. Abonneren op de podcast van BNR Zakendoen kan via bnr.nl/zakendoen, of via Apple Podcast en Spotify. See omnystudio.com/listener for privacy information.

De Nederlandse Vereniging van Commissarissen en Directeuren (NCD) zet zich al jaren in voor het dichten van de loonkloof. Nu komt minister van Sociale Zaken Eddy van Hijum (NSC) met een wetsvoorstel dat werkgevers verplicht om gelijke beloning tussen mannen en vrouwen te garanderen. Kan dat de toefkaart voor NCD zijn? Dat en meer bespreken we in het economenpanel van BNR Zakendoen Panelleden Presentator Thomas van Zijl gaat in gesprek met het economenpanel, dat deze keer bestaat uit: -Barbara Baarsma, hoofdeconoom van PwC Nederland en hoogleraar marktwerking- en mededingingseconomie aan de UVA. Wimar Bolhuis, Directeur TNO Vector - Centrum voor Maatschappelijke Innovatie en Strategie, en docent Economie Universiteit Leiden. Abonneer je op de podcast Ga naar de pagina van het economenpanel en abonneer je op de podcast, ook te beluisteren via Apple Podcast, Spotify en elke maandag live om 11:10 uur in BNR Zakendoen. See omnystudio.com/listener for privacy information.

In this episode, Sam Melamed, CEO of NCD, and Bret Voith, Chief Strategy Officer, discuss major regulatory shifts affecting ACA and Medicare Advantage. They explore how new policies may impact health plans, enrollment trends, and the growing demand for supplemental benefits like dental and vision coverage.

In this episode, Sam Melamed, CEO of NCD, and Brett Voith, Chief Strategy Officer, discuss major regulatory shifts affecting ACA and Medicare Advantage. They explore how new policies may impact health plans, enrollment trends, and the growing demand for supplemental benefits like dental and vision coverage.

Sam Melamed, CEO of NCD, discusses the evolving landscape of standalone dental insurance, exploring how shifting regulations, consumer preferences, and Medicare and ACA dynamics are influencing market opportunities and challenges.

In our Medicare Advantage Minute, we learn that ten companies are exiting MA markets in 2025. Do you need cognitive assessment? Some say that I do! Read all about how Medicare will pay for that plus care plan services. Finally, I use perplexity AI to provide information to prospects who are considering the purchase of dental & vision insurance. Ameritas and NCD by Metlife are the first two companies I suggest. There are many, many others to choose from! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A++)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2024; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Národná cena za dizajn (NCD) je prestížna celoštátna súťaž a najvyššie ocenenie v oblasti dizajnu na Slovensku. V aktuálnom 21. ročníku sa Národná cena za dizajn zameriava na súčasný komunikačný dizajn. Ojla sa o nej rozprávala s jej kurátorom a porotcom Jurajom Blaškom.

Asyraf has struggled with eczema since he was in preschool, growing up with the constant skin redness, persistent itching, and unpredictable flare-ups. Now 18, Asyraf is feeling hopeful for the first time, as he is receiving advanced therapy to control his eczema. On this episode of NCD Chronicles, he shares about the challenges he faced as a child and teenager with eczema, while consultant dermatologist Dato' Dr Noor Zalmy Azizan delves into how the itch associated with eczema isn't just merely an allergic reaction. We also explore eczema management strategies, from moisturisers to biologics. Find out how the Malaysian Skin Foundation can provide financial assistance for advanced therapies.NCD Chronicles is a series about people living with NCDs, going beyond the diagnosis to explore their personal experiences, their challenges, as well as the impact of their health condition on their loved ones. These stories reveal the importance of understanding the unique struggles and needs of the individuals behind the disease, in our response to the NCD epidemic.Image credit: Shutterstock

Hosts Kathe Kline and Joanna Wyckoff were joined by Jamieson Keller, Chief Commercial Officer at NCD, whose insights on dental insurance are invaluable for every Medicare agent. Cross-Selling Opportunities Jamieson emphasizes the importance of cross-selling dental insurance as a critical component of comprehensive client service. By integrating dental plans, agents can fill significant gaps in coverage that many clients overlook. This is not merely about augmenting sales; it's about addressing real healthcare needs. As Joanna Wyckoff noted, clients rely on their agents for full-spectrum coverage, making dental insurance an essential offer. Understanding the Value of Dental Plans Jamieson highlighted the need for agents to dive deep into dental insurance products to grasp their true value. Many plans offer significant in-network discounts, which can drastically reduce out-of-pocket expenses for clients. For example, the NCD by MetLife Dental Plans that Jamieson mentions provide phased benefits that improve over time, rewarding client loyalty and ensuring sustainable, long-term coverage. Mitigating Financial Pressures With recent changes in the Medicare Advantage (MA) and Prescription Drug Plan (PDP) spaces, where some carriers are cutting commissions, dental insurance stands as a viable alternative for agents to recoup lost income. Jamieson points out that level commissions from dental plans can offer financial stability for agents facing turbulent changes in the industry. Testimonial of Quality Care Jamieson's background adds credibility to his recommendations. With over 17 years in Medicare and three years focused on dental insurance, his experiences provide a robust framework for agents. His engaging discussion about network discounts underline the importance of personalized client education and well-researched plan selection. Call to Action Agents are encouraged to proactively ask clients about dental insurance. Jamieson suggests creative methods like using large tooth models to initiate conversations and attract attention at events. The simplicity of enrolling a client in an NCD dental plan, which takes only about 90 seconds, underscores its efficiency. Final Thoughts As the episode wraps up, the hosts reaffirm their commitment to utilizing Jamieson's insights. By attending webinars and leveraging the comprehensive resources available, agents can significantly enhance their service offerings and ensure their clients receive holistic care. The conversation reveals a compelling case for the strategic use of dental insurance within the realm of Medicare services, underscoring its critical role in client health and agent success.

What is it like living with a chronic condition from birth and to have a lifetime of managing health complications that would never go away? That's the reality for people born with spina bifida, one of the most congenital birth defects in the world. In this episode of NCD Chronicles, we hear from Su Xiao Vin, a person with spina bifida, on the challenges of living with less visible disabilities and how it affected her both at school and, later, at work. We also hear from Prof Dr Amaramalar Selvi Naicker, consultant rehabilitation physician and co-founder of Spina Bifida & Hydrocephalus Association Malaysia (SIBIAM).NCD Chronicles is a series about people living with NCDs, going beyond the diagnosis to explore their personal experiences, their challenges, as well as the impact of their health condition on their loved ones. These stories reveal the importance of understanding the unique struggles and needs of the individuals behind the disease, in our response to the NCD epidemic. —SIBIAM is organising the 30th International Conference on Spina Bifida and Hydrocephalus from 24th to 26th October in Kuala Lumpur, the first time this international event is hosted in Southeast Asia. To find out more and support the work of the conference and SIBIAM, go to www.sibiam.my.Image Credit: Su Xiao Vin

On June 26, 2024, B&C, along with the Environmental Law Institute and the George Washington University Milken Institute of Public Health, sponsored the all-day virtual conference, TSCA Reform — Eight Years Later. The quality of the discussion, the caliber of the participants, and the timeliness of the content motivated us to repurpose the substantive sessions. B&C and ELI are pleased to co-sponsor this episode of All Things Chemical® to enable our podcast audience to listen to these sessions. Samantha Liskow, Lead Counsel, Health Program, EDF, moderated Panel 3: New Chemical Review. The panelists included Shari Barash, Director, NCD, OPPT, EPA; Kyla Bennett, Ph.D., Director, Public Employees for Environmental Responsibility (PEER); Kerry Coy, Product Regulation Specialist, BASF Corporation; Richard E. Engler, Ph.D., Director of Chemistry, B&C; and Daniel Rosenberg, Senior Attorney, Environmental Health, Natural Resources Defense Council (NRDC). The panelists discussed the latest updates to EPA's new chemical review process, whether challenges are being addressed and how, whether review times are being diminished, scientific integrity, and best available science. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW. ©2024 Bergeson & Campbell, P.C.  All Rights Reserved

New church starts can be difficult. The Great Plains Conference's New Church Development board has implemented some new strategies and is, literally, traveling the world to see how it's done elsewhere. Todd explores some of the new strategies being employed by the NCD board to help build new faith communities that will thrive. In this episode, Todd talks with Rev. Dr. Gerald Liu, PhD, the conference's emerging faith communities cultivator; Amy Haines, a newcomer to the NCD board; and Rev. Changhyun Kim, who has started a new Korean-language faith community in Olathe, Kansas.

O significado de contribuir com a educação. O valor de ser solidário e compartilhar conhecimento em uma boa roda de histórias. Roberta Dietrich conversa com Josiane Piazza da Rosa, diretora de marketing do NCD, Bia Figueiredo e Paty Trier sobre a o NCD Solidário, uma ação anual do Núcleo de decoração e que em 2024 tem um olhar para educação. Conta pra gente o que vocês acharam do episódio?

Firefly Neuroscience Executive Chair Dave Johnson joined Steve Darling from to announce the company's strategic partnership with the Neurology Consultants of Dallas (NCD). This collaboration aims to enhance early detection efforts and improve disease management for patients experiencing cognitive decline. Johnson explained that NCD will integrate Firefly's Brain Network Analytics (BNA) technology into their patient workflow. This partnership also includes conducting clinical studies to identify biomarkers that could predict the onset of dementia, potentially optimizing patient care pathways. Furthermore, Johnson emphasized the significance of establishing a cognitive baseline for every patient. By doing so, healthcare providers can more accurately monitor cognitive changes over time, facilitating the early detection and effective management of cognitive decline. The incorporation of BNA technology is anticipated to revolutionize neurology testing across the United States, promoting the widespread adoption of advanced diagnostic tools and benefiting millions of patients. #proactiveinvestors #fireflyneiroscienceinc #nasdaq #aiff #brainhealth #neurologyconsultantsofdallas #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

For several months, JC suffered chest pains mimicking a heart attack. The tightening spread from his chest, up towards his neck. Then without warning, the heel pain appeared. He also had severe, unexplained fatigue. For a year, he battled these unpredictable symptoms of ankylosing spondylitis (now known as axial spondyloarthritis or AS), with little guidance. Now, with the help of the right treatment and a healthy fitness regime, JC's symptoms are well-managed, and he advocates for other people living with AS. Listen to his journey on this episode of NCD Chronicles and visit Axial Spondyloarthritis Malaysia to find out more about the local patient support group. NCD Chronicles is a series about people living with NCDs, going beyond the diagnosis to explore their personal experiences, their challenges, as well as the impact of their health condition on their loved ones. These stories reveal the importance of understanding the unique struggles and needs of the individuals behind the disease, in our response to the NCD epidemic.

August 20, 2024 Rockingham County Board Of Elections MeetingAGENDA1. Welcome / Call to Order2. Pledge of Allegiance3. Invocation – Pastor Ian PacePenn Memorial Church, Reidsville4. Approval of Agenda5. Approval of Board Minutesa. July 16, 2024 Regular Meeting Minutes6. Public Comments7. 2024 General Election Precinct Officials Appointmentsa. Early Voting Chief Judges & Judgesb. Election Day Chief Judges & Judgesc. Precinct Officials8. Director's Updates a. 2024 General Election Informationb. Photo ID Exception Forms Revisedc. NC State Board of Elections Summer Conference – August 4 – 6, 2024 – Koury Center, Greensboro, NCd. SAFE Assessmente. Board of Elections Renovation1. Board Meetingsf. September Board Meeting9. Adjournment###

Você por dentro de todas as ações do NCD! Neste episódio conheça o Programa de Relacionamento do NCD criado para profissionais arquitetos, designers de interiores, engenheiros e paisagistas. Junte-se ao NCD Lovers e viva experiências memoráveis.

Unexplained, sudden bruises. Wounds that take a long time to stop bleeding. For people living with haemophilia, bleeds - both externally and internally - are common because this condition affects the blood's ability to clot. We hear from Hariee Prabakaran, on what living with this rare inherited blood disorder is like as a child and adult, as well as from Dr Zulaiha Muda on how advances in treatment have changed the lives of people living with haemophilia. NCD Chronicles is a series about people living with NCDs, going beyond the diagnosis to explore their personal experiences, their challenges, as well as the impact of their health condition on their loved ones. These stories reveal the importance of understanding the unique struggles and needs of the individuals behind the disease, in our response to the NCD epidemic.

The Saint Lucian delegation comprised of the Chief Medical Officer Dr. Sharon Belmar- George and Senior Budget Analyst Ms. Merelicia Collymore who attended the high-level meeting on “International Dialogue on Sustainable Financing for NCDs and Mental Health” from June20-21st, 2024 in Washington DC, USA. Globally, Non-communicable diseases (NCDs) represent 74% of all deaths and 82% on a local level in Saint Lucia. Mental Health disorders account for one in six years lived with disability globally and we note these conditions continue to increase locally. Additionally, 1 in 7 children suffer from mental health related disorders globally, with at least 1 in 4 children requiring the assistance of caregivers. It is also indeed a sad reality that globally every 11 minutes someone dies as a result of suicide. Non-communicable diseases and mental health has been included in the 2030 Agenda for Sustainable Development- with the commitment to reduce premature mortality from non-communicable diseases by one third through the prevention, treatment and the promotion of mental health and well-being by 2030 (SDG target 3.4.1). Interestingly, only 3 countries are on the path to achieving this milestone. The effective management of NCDs and Mental Health require additional investments in health. Traditionally although public health is not revenue generating, the cost of the lack of investment into the primary/ preventative health system comes at a major cost to countries. It is paramount that the mindset of health as non-producing be shifted and instead be viewed as an agency that produces healthy individuals who can contribute positively to society. The benefits of health investment include healthy a population, increased productively of the working population and major savings in relation to hospital/secondary care. Through the implementation of national systemic strategies to prevent, manage NCDs and integrate mental health conditions as the focus of Primary healthcare and Universal Healthcare (UHC), it is imperative that the responses are positioned in the development of financing plans and resource allocation processes. The objectives of this meeting were to define and start building consensus among a range of stakeholders on actionable strategies and policy recommendations that can enable and enhance the integration of NCDs and mental health responses in national budget systems. This serves to ensure sustainable, adequate, stable and predictable financing to facilitate strategic purchasing and enhance financial protection to allow high quality, equitable NCD and mental health services on island. Dr. Belmar- George, who participated and presented during the conference was elated for the opportunity for dialogue and discussion between Health and Finance professionals at the international level. It provided an avenue for the Finance agencies to better understand the critical issues on the health agenda and the health agencies to familiarize themselves with the processes required to include important health initiatives into the national budget. In Saint Lucia like are countries in the region, governments are managing stagnant and declining budgets, with inflation, debt, with an ageing workforce, and working towards the implementation of UHC. It is necessary to allocate sustainable funding towards more cost-effective interventions to ensure that NCDs and mental health conditions are effectively addressed.

When we hear the word “dementia”, what many of us picture is often the last stages of the condition where the individual has lost much of their cognitive ability and memory. But that's only a small picture of what dementia really is. What are the lived realities of people living with milder forms of dementia and how can we support their ability to still be independent? On this episode of NCD Chronicles, we feature Vanetha Ramiah's journey of living with vascular dementia and the stigma she's had to battle along the way. We also hear from consultant geriatrician Dr Khor Hui Min. NCD Chronicles is a series about people living with NCDs, going beyond the diagnosis to explore their personal experiences, their challenges, as well as the impact of their health condition on their loved ones. These stories reveal the importance of understanding the unique struggles and needs of the individuals behind the disease, in our response to the NCD epidemic.

National Council of Disability, National  Council on Independent Living In a Month of Civil Right Remembrances & leading into April 2024, I wanted to include Disability Rights. A Movement over 50 years ago supported by the  Civil Rights & Black Panther Movements. The advances in Disability Legislation/ ADA was influnced by many people, including Black National Leaders who's names have been virtually forgotten in history. So lets explore them!Theo W. Braddy has advocated on behalf of people with disabilities for over 40 years. At the age of 15, he became a person with a disability due to a high school football accident that left him paralyzed from the neck down. In 1988, Braddy was hired as CEO of the Center for Independent Living of Central Pennsylvania, where he served for over 30 years. As CEO, Braddy created an independent living center that became a strong and growing voice for people with disabilities, and started the Living Well with a Disability Initiative. H e currently serves as Executive Director of the National Council on Independent Living (NCIL). He has taught at Temple University and Millersville University as an Adjunct Professor. Two different Governors have appointed Braddy as a Commissioner for the Pennsylvania Human Relations Commission and to serve on the Pennsylvania Statewide Independent Living Council. In 2021, Governor Wolf appointed him to serve on the State Board of Vocational Rehabilitation. In 2022, Braddy was selected by Senator Robert Casey, Jr., as one of four Black leaders in Pennsylvania who has demonstrated power and persistency in overcoming challenges and creating meaningful change in the State, and his contribution was acknowledged on the Senate Floor at a Congressional Hearing. He graduated from Temple University with his MSW in 1988 after receiving his BSW from Edinboro University. Ncil.org, NCD,gov

www.patreon.com/banjopodcast   This episode features Brian Alley, a great player in both the 3-finger and clawhammer styles. He is best known for performing and recording with his band: Portland, Oregon-based band Never Come Down. NCD have been gaining major steam on the bluegrass/jamgrass scene, and have a new record to be released in early 2024 titled "Greener Pastures" (produced by Chris Pandolfi).   Sponsored by Peghead Nation, Elderly Instruments, and Sullivan Banjos.   Brian on the web: https://nevercomedownband.com/   Contact the show: pickyfingersbanjopodcast@gmail.com

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: CE-incubated tobacco & NCD policy Charity: updates, funding gap, and future plans for Concentric Policies, published by Yelnats T.J. on December 29, 2023 on The Effective Altruism Forum. Executive Summary Tobacco is a massive global issue: 8 million annual deaths and 230 million annual DALYS (15% and 9% of global totals respectively). There are evidence-based policies - outlined by the WHO's MPOWER framework - that countries can adopt to reduce tobacco use. Policy advocacy for implementing MPOWER measures in neglected countries can avert DALYs with cost-effectiveness matching GiveWell's top charities. Since starting in mid-September, Concentric Policies has engaged with seven ministries of health, met with four, and received a partnership request from one to develop a multisectoral plan for noncommunicable diseases. Closing our Year 1 funding gap ($21,000) is critical for building the necessary capacity to support our government advocacy plans in 2024. About Us Concentric Policies is a nonprofit focused on preventing and controlling noncommunicable diseases. We support the adoption of evidence-based health policies in countries underserved by large NGOs and the international community. Through collaboration with governments, civil society, and citizens, we aim to reduce the unhealthy consumption of tobacco, alcohol, sodium, and sugar. Concentric Policies provides free assistance by engaging stakeholders, strengthening the evidence base through research, and offering technical assistance throughout the policy process. Concentric Policies was launched through Charity Entrepreneurship, a London-based incubator that turns well-researched ideas into high-impact organizations. Charity Entrepreneurship has helped launch over 30 charities that are now reaching over 20 million people annually with their interventions. Problem Annual deaths from tobacco were 6 million in 2013 and rose to 8 million before the pandemic. Today, more people are killed annually by tobacco usage than malaria, HIV, and neonatal deaths combined… twice over.[1] In addition, tobacco usage increases healthcare expenditures, decreases productivity, exacerbates inequality, degrades the environment, and contributes to child labor. This EA Forum post from World No Tobacco Day covers these harms in more detail. Solution The WHO's MPOWER framework provides cost-effective demand-reduction measures to help countries reduce tobacco consumption. Since MPOWER was introduced globally 15 years ago, an estimated 300 million less people are smoking than might have been if smoking prevalence had stayed the same.[2] Tobacco taxation is the most effective (and cost-effective) intervention for reducing tobacco consumption, yet it is the most neglected intervention.[3] Tobacco has an average price elasticity in LMICs of around -0.5, meaning that for a 10% increase in the retail price of tobacco, consumption decreases by 5%.[4] Opportunity The number of countries that have adopted at least one MPOWER measure at the highest level of achievement has grown from 44 in 2008 to 151 in 2022. However, only a handful of nations have full compliance with MPOWER guidelines and 44 countries remain unprotected by any of the MPOWER measures.[5] Despite nearly every country signing the WHO's treaty on tobacco, only 13 nations outside of Europe meet the WHO's recommended minimum of taxing tobacco at 75% of retail value. Since starting work in September, we have learned and reaffirmed the following: Some governments are not aware of the potential ROI from comprehensive implementation of the MPOWER framework Consolidated funding in the tobacco control space has led to only a dozen or so of the highest-burden countries receiving the majority of resources Many smaller countries do not receive any attention from major tobacco control organizat...

The NCD has found their culprit, but there's not much time left to stop their plans and save Christmas once again. Luckily, some help from an old friend may be just the thing they need to save the day!Starring Sky Swanson (Christmas Keeper), Casey Reardon (JEREME), Rachel Kordell (Kevin), Jonas Tintenseher (Phoebe Morganstern), Andrew Frost (Todd Dodds), Seth Coveyou (Peppermint Schnapps), and Chris Dane (Arvoitus).Ambience sourced from Tabletop Audio (CC BY-NC-ND-4.0). "Deck the Halls B" and "Up on a Housetop" by Kevin MacLeod (incompetech.com, CC BY 4.0).

This is an audio version of my new chapter with Justin Farrell in the new Handbook of the Sociology of Morality, V2 (2023) called "The Influence of the Nature-Culture Dualism on Morality." The new handbook was edited by Steven Hitlin, Shai M. Dromi, and Aliza Luft and is out from Springer-Verlag New York, LLC. Abstract: Nature and culture are perhaps the two most consistent moral categories in Western thought. And yet, despite their stability, what nature and culture represent within a given moral system varies widely. In this chapter, we argue that the nature-culture dualism (“NCD”) has a fundamental impact on the moral imagination of different societies, and that this relationship has been underappreciated by sociology. To illustrate our argument, we trace the evolution of nature-culture dualism (“NCD”) from Greek and Roman thought, through Medieval Christian thought, and into the Modern era, from which sociology emerged. We show how in each era different presuppositions are stabilized by metaphors that naturalize a particular nature-culture dualism and set of moral beliefs, first about how humans should treat nature, and second, about what type of society nature is telling humans to build. Moving forward, sociologists should pay closer attention to the nature-culture dualism, not only because it is analytically important but because moral imagination is impossible without it.

In this episode, Sujani sits down with public health physician Dr. Arunah Chandran. They discuss Arunah's clinical work and how she became interested in the field of public health, her work at the Ministry of Health of Malaysia and experience moving to France to work with the IARC, and share job application tips for those interested in working with international organizations. You'll LearnThe clinical encounters that led Arunah to becoming involved in the field of public health What additional training Arunah went through to become a public health physicianArunah's research and work in noncommunicable diseases and women's health with the Ministry of Health in MalaysiaFinding different job opportunities within the same company or systemAdvice on how to figure out if you should seek an additional degree or notArunah's work with the IARC and her experience moving to a different country for workTips on applying for jobs with international organizations and the benefits of keeping a log of values and responsibilities you have had at every positionToday's GuestPublic health medicine specialist, with experience in clinical medicine, health systems, NCD policies, public health operations, and clinical research. Led national policy response for cardiovascular diseases, diabetes, and cancers in Malaysia. Currently, focused on implementation and evaluation of affordable and equitable integrated multi-cancer early detection package to improve cancer outcomes in resource-constrained settings. Initially trained as a physician, I have a double Masters in Public Health and Medical Aesthetics/Anti-aging as well as a doctorate in Public Health (Epidemiology).ResourcesConnect with Arunah on LinkedIn Learn more about the International Agency for Research on Cancer Listen to the previous episode on the Public Health Resume and CVSupport the showJoin The Public Health Career Club: the #1 hangout spot and community dedicated to building and growing your dream public health career.

Nalini Saligram, Ph.D, is the Founder & CEO of Arogya World, a global health non-profit committed to changing the course of chronic disease. She is an Ashoka Fellow. Under Nalini's leadership, Arogya World designs and implements scalable, science-based diabetes prevention programs in Indian schools, workplaces, and the community. As a tireless advocate for NCD prevention, Nalini leverages public-private partnerships and global platforms to improve the world we live in. Arogya World has made three Clinton Global Initiative Commitments (one in 2011, and two in 2013), a United Nations Every Woman Every Child Commitment (2014), was active with MIT's SOLVE effort (2017), and was named a finalist for the Peter F. Drucker Award for Nonprofit Innovation (2014).  Her story and that of Arogya World has also been highlighted in a book – The Healthcare Gamechangers.  In 2021, on her watch, Arogya World was chosen to be part of the Google AI for Social Good effort. Nalini has lived and worked in many parts of the world, including Merck in Philadelphia, Merial in Atlanta, Glaxo Wellcome in London, and Hill & Knowlton in Hong Kong.

Elizabeth Adeshina is the CEO and founder of Wazima Health, a digital health company providing telemedicine, remote patient monitoring, and health education services through their platform. Their primary goal is to ensure access to affordable screening and treatment for noncommunicable diseases across Africa. Knowing my passion for NCD prevention and treatment, this podcast is dedicated to exploring the work of Wazima Health. Please join me on this journey with their extremely enterprising CEO. For more information about Wazima Health please visit: https://www.wazima.health/ MedxTek Africa is produced and hosted by Dr Sam Oti, and co-edited by Veronica Ojiambo. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

Join us again as we get to know more about Crosbee Lisser, North Central District President, and hear about her experiences within the Fraternity.

In this mini podcast, discover NCD and find out why you want to attend the May 17th broker webinar to learn about their portfolio of products. Register for this Webinar --- Send in a voice message: https://podcasters.spotify.com/pod/show/coffeewithchris/message

Ta Morrison is the CEO and Founder of Star Class Travel, a luxury full-service travel agency and hand-crafted and pored T-Lites Candle company in Houston, Texas. Ta became the Texas Ambassador for National Curves Day, Inc. in September 2016 because she saw a need for outreach in her local community. She is currently the Global Director and ambassador for National Curves Day and shares their mission to embrace, encourage, and empower women and men in the plus-size community by teaching them to self-embrace, self-identify, and self-love. She recently helped launch the Plus Travel Network, a division of NCD that is a cultural collective dedicated to redefining world experiences for the big & tall and plus size community. The inaugural Body Confidence Fest is happening August 3-7, 2023 in Punta Cana, Dominican Republic!

Battling cancer takes place in many parts of the world and our next guest has led initiatives to do just that. In Part One of this Oncology, Etc. Podcast episode, Dr. Richard Sullivan, Professor of Cancer and Global Health at King's College London, shares with us his intriguing life trajectory, encompassing a childhood in various parts of the world, aspirations for a veterinary career that turned to basic science, medicine, health policy (4:27), and even a long-term stint with the British Army Intelligence (12:22). Dr. Sullivan, who served as Director of Cancer Research UK for nearly a decade also discusses traits he looks for in a cancer investigator (19:21), and how to be happy (21:16)! Guest Disclosures Dr. Richard Sullivan: Honoraria – Pfizer; Consulting or Advisory Role – Pfizer Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical If you liked this episode, please follow. To explore other episodes, as well as courses visit https://education.asco.org. Contact us at education@asco.org. TRANSCRIPT  Pat Loehrer: Hi, I'm Pat Loehrer. I'm director of the Center of Global Oncology and Health Equity at Indiana University Cancer Center.   Dave Johnson: And I'm Dave Johnson at UT Southwestern in Dallas, Texas.   Pat Loehrer: And this is Oncology, Etc. Dave, what book have you read this last month?   Dave Johnson: I have one I wanted to recommend to you. It's very interesting. It's by Steven Johnson, not of the syndrome fame. It's entitled Extra Life: A Short History of Living Longer. You may have heard of this because PBS made a special documentary about this particular book. But in it, Johnson talks about the remarkable increase in human lifespan, especially over the 20th century, and the various factors that contributed to increased years of life from on average in the United States of about 48-49 in 1900 to just about 80 in the year 2000. So that beats anything in the history of mankind before.   And he has a chapter about each of the factors that contribute to this, and some of which I think we all recognize. Things like antibiotics playing a role, but some of the things that I hadn't thought about were improved drug regulation and the development of randomized controlled trials, which all of us have participated in. How important that is.   He also talked about, at least in the United States, the importance of automotive safety. And I'm sure some of us on this podcast are old enough to remember cars that did not have safety belts and certainly not other safety maneuvers that have really improved lifespan in that regard. So I found it a fascinating book. I think our listeners who are interested in medical history would also enjoy this text.   Pat Loehrer: Did he mention this podcast?   Dave Johnson: No, actually it wasn't mentioned, and I thought that was a tremendous oversight. So, I've sent him a letter and recommended that he add it.   Pat Loehrer: We may not live longer, but it just seems like we're living longer. When you listen to this podcast, time stands still.   Pat Loehrer: Well, it's my real great pleasure to introduce our interviewee today, Richard Sullivan. I met Richard several years ago through the late Professor Peter Boyle in Leon, and it's one of the greatest highlights of my life to be able to know Richard.   Professor Richard Sullivan's Research Group studies health systems and particularly chronic disease policy and the impact of conflict on health. He's a professor of cancer and Global Health at King's College in London and director of the Institute of Cancer Policy and Co-director of Conflict and Health Research Group. As well as holding a number of visiting chairs, Richard is an NCD advisor to the WHO, a civil military advisor to the Save the Children Foundation, and a member of the National Cancer Grid of India. His research focuses on global cancer policy and planning and health system strengthening, particularly in conflict ecosystems. He's principal investigative research programs ranging from automated radiotherapy planning for low resource settings to the use of augmented or virtual reality for cancer surgery through the political economy to build affordable equitable cancer control plans around the world.   Richard has led more Lancet Oncology commissions than anyone else. In fact, Lancet is talking about calling it the Sullivan Commissions. He's led five Lancet Oncology commissions and worked on four others. He's currently co-leading the Lancet Oncology Commission on the Future of Cancer Research in Europe and Cancer Care and Conflict in the conflict systems. His research teams have had major programs in capacity building in conflict regions across the Middle East and North Africa. He's done studies on the basic packages of health services in Afghanistan and worked in Pakistan, Syria, and the Democratic Republic of Congo. He's been a member of the British Army, intelligence and security, and in that capacity he's worked many years in biosecurity and counterterrorism issues. I think in some ways, this is the most interesting man in the world, and it's our pleasure today to have Richard join us. Richard, thank you for coming.   Richard Sullivan: Pat, Dave, you're really too kind. Marvelous to be with you. Thank you for the invitation.   Pat Loehrer: Can you tell us a little about your upbringing and early life before you became Dr. James Bond?   Richard Sullivan: I'm not sure that's anywhere close to the truth, sadly. But, yeah, I have had a very interesting, eclectic life. I was born in Aden just on the cusp of where the British Aden Protectorate met a country which actually no longer exists, the People's Democratic Republic of Yemen. Because after the British left Aden, essentially the East Germans, and what was then the Soviet Union took over southern Yemen. So I was born in a very unusual part of the world, which sadly, since then has just deteriorated. I spent many years of my life with my parents, who were in the diplomatic service and doing other things, wandering around the globe, mainly in the Middle East and East Africa. We spent quite a lot of time, strangely enough, we washed up on the shores in the USA once as well. Dayton, Ohio, and eventually-   Pat Loehrer:  Not to interrupt you, Richard, there are no shores in Dayton, Ohio. So just correct you there.   Richard Sullivan: That is so true. My memory - cornfields everywhere. I had a wonderful dog then, that's how I remember it so well. And I didn't really come back to the UK until, oh, gosh, I was nearly 10-11 years old. So, coming back to the UK was actually a bit of a culture shock for me. And then relatively classical in terms of the UK, sort of minor public school and then into medical school. In the old days when it was in the 80's. I had a fabulous childhood, going all over the place, seeing lots of things, being exposed to lots of different cultures. I think it remained with me all my life. I never really feel a foreigner in a foreign land. That's nice. That's really unique and it's been marvelous being able to tie in the passion for global health with my upbringing as well. So, yeah, I had a wonderful childhood.   Dave Johnson: Would you mind expanding on your medical training, Richard? Tell us a little bit about that.   Richard Sullivan: Yeah, so when I, when I went to medical school in the UK, we were still running the old system. And by the old system, I mean, you know, these small medical schools with entries of, you know, 70, 80 individuals, particularly in London, you had that St. Mary's Hospital Medical School, which is where I went, Charing Cross, Guy's, St. Thomas', and they were all individual medical schools. Now, most of these now have merged together into these super medical schools. But certainly when I went to medical school, I'll be absolutely honest with you, I wanted to be a vet to begin with, but actually discovered I wasn't bright enough to be a vet. It was harder to become a vet than it was to become a doctor. In my day going into medicine, and people listening to this, or some people who understand the A level system in the UK will recognize if you're offered a BCD, that's quite low grades to get into medical school. So I went to Mary's, to be absolutely honest with you, because I heard that they took people that played rugby, and I came from a rugby-playing school. And sure enough, 90% of the interview was based on my rugby prowess, and that was St. Mary's Hospital Medical School. So it was wonderful.   And we'd already had people going there who were big rugby players. And again, it was, I remember thinking to myself, am I making the right decision here? But it was interesting, as soon as I went into medical school, I realized that was the life for me. I had done myself a favor by not going into veterinary science, which I would have been awful at. We had six years of very, very intensive pre-medicine, the classical medical rotations, and then that movement into the old schools of pre registration house officers, registrar jobs. We were quite an early stage. I kind of slightly went off-piste and started doing more academic work. Interestingly, most of my academic early days academic work was not in health policy and research. It was actually in very hard core cell signaling. So my doctorate was in biochemistry, and we worked on small GTPases, calcium-sensing proteins.   There were some really extraordinary heady days, and I'm talking here about the early nineties and the mid-nineties of tremendous discovery, real innovation. I was at UCL at the time, but mixing and matching that up with a sort of surgical training, and again, surgical training in those days was pretty classical. You went into your general surgery, then sort of specialized. It was really, really interesting but it was full on. I mean, you spent your entire life working. Morning to night so these were the days of 100 hours week rotations. You were doing one in twos, one in threes. That's every other night and every other weekend on call. It was incredibly intense, but there was a lot more diversity and plasticity in those days. You could dip in and out of medicine because of the way you were chosen and how you were recruited. So it suited my personality because I liked moving around and doing different things and that sort of took me through, really until the late 1990s.   Pat Loehrer: You became a urologist, right?   Richard Sullivan: That's right. Exactly. So I trained up until the late 1990s, it was all pretty standard, I would say. And then I decided I was bored and moved into the pharmaceutical industry and I went to work in for Merck Damstadt at the time, which was relatively small. I was going to say family owned, but it was quite family-owned pharmaceutical company that was just moving into oncology. And because I'd done the background in cell signaling and cell signaling was really the backbone of the new era of targeted therapies, this seemed like a great move. To be absolutely blunt with you, I didn't last very long, less than a couple of years, I think, mainly because I just found the whole environment way too constraining. But what it did provide me with was a springboard to meet the wonderful late Gordon McVie, who I met at a conference. And he said to me, ‘You're absolutely wasting your time and life by staying in the pharmaceutical industry. Why don't you come out, get an academic job at University College London and become my head of clinical programs?” - for what was then the Cancer Research Campaign. This Cancer Research Campaign and the Imperial Cancer Research Fund were the forerunners of Cancer Research UK. So, you know, this was an offer that was too good to be true.   So I jumped ship immediately, went back into academic life and joined CRC. And really the next ten years was this extraordinary blossoming of the merger of CRC with the Imperial College Research Fund, the creation of Cancer Research UK, and that was Paul Nurse, and obviously Gordon and me, bringing that all together. And it was the heady days of that resurgence of cancer, the importance of cancer care and research in the UK. And coupled with that, of course, it was the blossoming of my interest, really then into the global health aspects of cancer, which really, Gordon, people like you mentioned already, the late, wonderful Peter Boyle, all those individuals were already engaged in and they were the ones that really kind of catapulted me into a more international scene.   Dave Johnson: Did you know Dr. McVie before you met him at this conference, or was it just a chance encounter?   Richard Sullivan: No, he actually met me via John Mendelson, because John had picked up a paper I'd been writing on basically the very early versions of Rituximab that we were working on and we were looking for pharmacodynamic endpoints. And of course, one of the things I noticed with the patients is they were getting all these skin rashes on their faces, and I thought, that's terrific. Just seemed to be the skin rashes seemed to be together with those individuals that had better responses. And I remember writing this paper for Signal, which was a kind of relatively minor journal, and I think it was John Mendelson who picked it up and must have mentioned something to Gordon. Gordon hunted me out down at a particular conference, said, "How on earth do you know about this, that you're not anything more than a surgeon?" He was absolutely right about, goodness sake, what do you know about pharmacodynamic endpoints, and I kind of had to sort of confess that I've gone kind of slightly off-piste by doing biochemistry and cells signaling and working with these extraordinary people. And that's how I essentially met Gordon. He was very good for spotting slightly unusual, eclectic human beings.   Pat Loehrer: I'm very curious about the intersection of your work and how you got into the British Army and Intelligence with medicine and how that even may continue even today. So explain that story, that part of your life a little bit to us.   Richard Sullivan: Yeah, it was very early on, as I went into medical school, one of the key concerns was making money. I looked around for ways of doing something interesting to make money, and most of the jobs on offer were bar jobs, et cetera. Then I thought, what about the Territorial Army, which, in the early days of the 1980s, was, and still is, a very large component of the UK Armed Forces. So I actually joined the Royal Army Medical Corps, as you would expect for someone going into medicine. I thought, okay, I'll join the Royal Army Medical Corps, and I was a combat Medical Training Technician, et cetera. So I went along, signed up, and I think I was about three months into training when I was at a place called Kew Barracks and some chap came up to me and handed me a little bit of paper. It said "Intelligence Security Group" and gave a phone number. He said, "This is more your line of work. Why don't you give them a ring?"   It was interesting because, in those early days, they were looking for analysts who could work on lots of different areas. In those days, most of the work was domestic.. Of course, there was counterterrorism with Northern Ireland, but there was also the Soviet Union, and the fallout from the Warsaw Pact, so they were still actively recruiting into that area. There are lots of details I can't talk about, but it was relatively, to begin with, quite hard work and low level. It was a lot of learning foreign equipment recognition. It was what we consider to be standard combat intelligence. But the more time you spend in it, the more interesting it gets.   One of the areas they were looking to recruit into, which I didn't realize at the time but only later, was bioweapons and biosecurity. They needed people who understood biotechnology and the language of science, and who could be taught the language of infectious disease on top of that. That is quite a difficult combination to find. It's very easy to teach people trade craft and intelligence, it's very hard to teach them subject matter expertise. And they were really missing people who specialized in that area.   It was interesting because it was still a relatively open domain. There was still a lot of work going on in the counterterrorism front with biological weapons, and a lot around the Verification of the Biological Weapons and Toxin Convention. And it was an interesting, and I'd almost say parallel life. But your medical knowledge and the scientific knowledge I had already gained and was gaining was what was being looked for. So that was very early on and it has expanded over the years. More and more now we talk about health security and intelligence so that goes beyond what you would consider classic medical intelligence or Armed Forces - this is more about putting together the disciplines of intelligence with the securitized issues of, for example Ebola. That is a classic example. The big outbreaks in West Africa, the DRC, these are sort of the classic security intelligence issues - even COVID 19 for example - and mostly around the world, what we've seen is the intelligence apparatus taking front and center in that, whether you're looking at states like South Korea, et cetera. So I've moved more into that, and we do a lot of work and research into this as well. So we look at, particularly now, how to improve human intelligence in this area, the pros and cons of signal intelligence collection. And we go as far as to kind of ask sort of deep ethical and moral issues, for example, about how far should these sorts of apparatus of state be applied to public good issues like health. Because at the end of the day, when you're talking about the armed forces security sector, their primary job is for defense of the realm. So applying them in other areas obviously comes with a whole load of moral and ethical challenges. So, yes, it's been a fascinating journey, which, as I said, it extends all the way back to the late 1980s. It's been both complementary and different.   Dave Johnson: So, Richard, there's so many things in your resume that warrant exploration, but you served as Clinical Director of Cancer Research UK for nearly a decade. What was that experience like, and what accomplishment are you most proud of?   Richard Sullivan: It was an enormous privilege. In your life, you always look at some jobs and you think, “How lucky I was to be there at that time with those people.” I think, first of all, enormous respect for the people that ran both Cancer Research Campaign, Imperial Cancer Research Fund – I mean, Paul Nurse and Gordon McVeigh, Richard Treisman – I mean, some extraordinary people who were leading both of these charities. And so to be there at that moment when they both came together, but more importantly as well, they had this most amazing global network of literally the illuminati of cancer research, spanning from basic science all the way through to epidemiology, public health, health systems. And in those days, of course, those individuals would come on site visits to the UK to look at the different units and evaluate them. So you can imagine when you're bringing those sorts of individuals across, you get a chance to go out with them, go drinking, talk to them, learn about their research, and also learn about the extraordinary breadth of research that was there in the UK. So you're condensing almost a lifetime's worth of learning into a few years. It was an absolute privilege to have been able to serve the community like that.   What I'm most proud of? Gosh, I like to think I suspect that most proud of trying to help a lot of the fellows get through to where they were going to actually get the most out of their careers. When I look back, there are lots and lots of names of people who started at a very early stage with funding from Cancer Research Campaign or the Imperial College Research Fund, who are now very, very senior professors and global research leaders. And I like to think that we did a little bit to help them along that way and also help to support individual research programs actually reach their full potential. Because I think research management and planning is often overlooked. People think of this as very transactional – it's not transactional. It's an incredibly important, serious discipline. It requires very careful handling to get the very best out of your research ecosystem. You've really, really got to get under the skin and really have a clear view of how you're going to help people. So I think that's what I'm most proud of – is the individuals who made it all the way through and now these great leaders out there.   But it was also, let's be honest, it was halcyon days. Great innovations, great discoveries, new networks growing, incredible expansion of funding in the UK, in Europe, in the USA. They were very, very good days. And it was, as I said, it was a real privilege to be there almost at the center for nearly a decade.   Dave Johnson: Let me follow up on that, if I may, just for a moment. You have had such an incredible influence. What characteristics do you think are most desired in a cancer investigator? What sorts of things do you look for, especially when you're thinking about funding someone?   Richard Sullivan: Creativity. I think creativity is really important. We talk about the word innovation a lot, and it's an interesting engineering term, but creativity is that spark that you can see it in people, the way they talk about what they're doing. They have this really creative approach. And with that, I think you have to have the passion. Research careers are long and difficult, and I'd probably suggest there's probably more downs than there are ups, and you have to have that passion for it. And I think along with that passion is the belief in what you're doing – that first of all, you have that belief that actually drives you forward, that what you know you're doing is good work, and that you're really dedicated to it. But obviously, hand on heart, when you're looking at researchers, it's that passion and that creativity.   I think it's a brave person to judge how any person's career or program is going to go. I don't think any of us are prophets. Even in our own land. We might be able to see slightly into the future, but there are so many elements that make up  “success”. It's funny when I look back and I think those who've been successful, it's people who've also been generally happy in their lives. They've found their careers in whatever shape or form, fulfilling, and they've generally been happy human beings, and they've managed to create a life around research which has given them meaning.   Pat Loehrer: Richard, you have reinvented yourself a number of times – this transition of going from like a basic scientist, a surgeon, moving into public policy and global policy. Tell me a little bit about the journey that's been in terms of academics. How do you learn? What were the transition points in each of these things to get you now to be, as I mentioned before, kind of the key person for Lancet's commissions to somebody who was a rugby player?   Richard Sullivan: I suppose if you're being mean, you say, he clearly gets bored easily. But it's not that. Actually, I'm not very instrumental about life either. I mean, there are many people you will meet who have got their lives and strategies mapped out. They know they're going to do X next year, Y the following year. And for me, it's never been like that. For me, it's that excitement, that creativity of working on new and interesting things, but also knowing when you've run out of road in a particular area, where it no longer gets you out of bed in the morning, where you no longer feel happy, where you no longer feel you're contributing. All of us talking today have the great privilege of having choice about our lives, about what direction our lives should take. And it's not a privilege one should squander lightly because many people do not have choices about their lives. It's all about chance. And having that choice to be able to move into different areas is really important because I said you can stick in the same thing because you think you have to. And you can become an unhappy, miserable human being. And that makes you a miserable researcher to be around. It makes you a terrible doctor. Probably makes you a terrible person, actually, generally, if you're having a miserable life.   So finding new things, that really you're passionate about how you do it, there's no shortcut in this. It's hard work. Readily admit I went back to law school of economics, retaught myself lots of things. There are no shortcuts for. Deciding if you're going to a new area is learning, learning, practice, practice, practice, and just doing the hard work. I think that's an ethos that was probably drilled into us quite early anyway in medical school, because that's how you approach medicine. That's how you approach science when I was growing up. And it was that idea of humility that you can never have enough learning, you will always learn off other people. That's probably what drove me and how I've managed to change and as I say, who knows what the future is? I don't know. Maybe one day I'll think about doing a bit of poetry.   Dave Johnson: Your comments about happiness and work resonate with Pat and me. I think we both feel like humor is really important for happiness and career success. And, you know, Osler once said, “The master word of medicine is work.” You can't get around that. It is what it is. And I think you just reaffirmed that.   Well, this concludes part one of our interview with Richard Sullivan, professor of Cancer and Global Health at King's College, London and director of the King's Institute of Cancer Policy and co-director of the Conflict and Health Research Group. In the second part of this episode, Professor Sullivan will speak about the progress of global health, especially in conflict areas, and the need for young people to enter into the world of oncology and oncology research.   Thank you to all of our listeners for tuning into Oncology, Etc. This is an ASCO educational podcast where we will talk about just about anything and everything. So if you have an idea for a topic or a guest you would like us to interview, please email us at education@asco.org. Thank you again for listening.  Thank you for listening to the ASCO Education podcast. To stay up to date with the latest episodes, please click subscribe. Let us know what you think by leaving a review. For more information, visit the Comprehensive Education Center at education ASCO.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.  

While Malaysia can take pride in its level of healthcare services for maternal and child health, as well as for infectious diseases and most acute emergency conditions, the same cannot be said of access to health services for people with non-communicable diseases (NCDs). The provision of care can be uneven depending on certain geographical and socio-economic barriers, while the health system is straining to cope with the increasing burdens of NCDs and the ageing population. Dr Murallitharan Munisamy, Managing Director of the National Cancer Society of Malaysia, and Co-Chair of NCD Malaysia, joins us on the first show of 2023 to highlight the gaps in universal health coverage across the spectrum of NCD care, and why it's important to have “many small umbrellas” to support people with NCDs, rather than one giant umbrella from a struggling public health sector.Photo credit: Shutterstock

Welcome to this episode! Join editor & host, Ryan Smith, as he interviews Arden Gunnerson, North Central District Secretary/Treasurer, about her journey in Kappa Kappa Psi and goals for her District. Transcription coming soon. Questions, Comments, Suggestions: smity@kkpsi.org

Wakati dunia ikiadhimisha hii leo siku ya kisukari duniani kwa lengo la kuelimisha umma kuhusu ongezeko la mzigo wa ugonjwa huo na mikakati ya kuzuia na kudhibiti tishio lake, bara la Afrika linaonekana kuwa na changamoto kubwa ya ugonjwa huo, kwa mujibu wa takwimu za shirika la Umoja wa Mataifa la afya duniani, WHO.   Flora Nducha na taarifa zaidiTakwimu zilizotolewa leo na WHO kanda ya Afrika zinaonyesha kiwango cha changamoto ya ugonjwa wa kisukari Afrika ni kubwa ambapo watu wazima milioni 24 hivi sasa wanaishi na ugonjwa wa kisukari na idadi inatarajiwa kuongezeka kwa asilimia 129 hadi kufikia watu million 55 ifikapo mwaka 2045. Kupitia ujumbe ake wa siku hii Dkt. Matshidiso Moeti mkurugenzi wa WHO Kanda ya Afrika amesema “Mwaka janga ugonjwa wa kisukari ulikatili maisha ya watu 416,000 barani Afrika na ugonjwa huo unatarajiwa kuwa miongoni mwa vyanzo vikuu vya vifo Afrika ifikapo mwaka 2030. La msingi zaidi ni kwamba kisukari ndio ugonjwaa pekee usio wa kuambukiza ambao hatari yake ya vifo vya mapema inaongezeka badala ya kupungua.” Mkuu huyo wa WHO Afrika ameendelea kusema kwamba “Sababu kuu hatari zinazochangia ongezeko la ugonjwa huo Afrika ni pamoja na  historia ya familia, ongezeko la umri na sababu zingine maarufu kama uzito wa kupindukia na utipwatipwa, maisha ya kukaa bila mazoezi, lishe isiyofaa, uvutaji wa sigara na unywaji pombe kupita kiasi. Kwa bahati mbaya, sababu hizi za hatari zinazoweza kubadilishwa zinaongezeka katika nchi zote katika Kanda ya Afrika ya WHO.” Dkt. Moeti amesema “Na changamoto kubwa katika juhudi za kukabiliana na ugonjwa huo ni ukweli kwamba zaidi yam to 1 kati ya kila watu wawili barani Afrika anayeishi na kisukari hajawahi kupimwa  na hivyo kuongeza fursa za nyenzo za upimaji na dawa kama insulin,ni moja ya maeneo yanayopaswa kufanyiwa kazi haraka.” WHO imeonya kwamba ukiachwa bila kudhibitiwa, na bila usimamizi na mabadiliko ya mwenendo wa maisha, ugonjwa wa kisukari unaweza kusababisha matatizo mengine mengi.  Matatizo hayo ni pamoja na mshtuko wa moyo, kiharusi, figo kushindwa kufanyakazi, kukatwa kwa viongo vya mwili kama miguu,  ulemavu wa kutoona, upofu, na uharibifu wa mishipa.  Limeendelea kusema shirika hilo kuwa watu walio na ugonjwa wa kisukari pia wako katika hatari kubwa ya kupata dalili kali za COVID-19. Dkt. Moeti amesisitiza kuwa “Leo, tunapoadhimisha siku ya kisukari duniani, ninataka kuchukua fursa hii kutoa wito kwa serikali za nchi wanachama kuweka kipaumbele katika uwekezaji wa bidhaa muhimu, kama vile dawa za insulini, macshine za kuangalia kiwango cha sukaru glucometer na sindano zinazotumika kupimia au strips. Hii ni muhimu ili kuhakikisha fursa sawa kwa kila mtu anayeishi na ugonjwa wa kisukari, bila kujali ni wapi aliko katika bara hili.” Pia amezihimiza serikali za Afrika kupitisha na kubinafsisha malengo ya kimataifa ya ugonjwa wa kisukari, kama sehemu ya mapendekezo ya kuimarisha na kufuatilia hatua za ugonjwa wa kisukari ndani ya programu zao za kitaifa za NCD. Siku ya kisukari duniani huadhimishwa kila mwaka Novemba 14 na maudhui yam waka huu kama yalivyokuwa yam waka jana na yatakavyokuwa mwakani ni “Fursa ya huduma za kisukari” yakisisitiza umuhimu wa kuzuia na juhudi za hatua dhidi ya kisukari. 

Welcome to season 2, episode 44 of the Today is the Day Changemakers Podcast.This week my guest is Dr. Andrea Feigl, Founder and CEO of Health Finance Institute. Andrea was born and raised in Austria. In her junior year of high school she was one of only two students in Austria chosen to go to United World College. She came to the U.S. and went on to receive her Ph.D in global health from Harvard University. Dr. Feigl brings extensive leadership experience in academia, the public sector international organizations (WHO, WB, OECD), and the global non-profit sector with her. Andrea's work focuses on health systems financing and governance, universal healthcare, and cost-effectiveness of chronic disease interventions in developing countries. She led the largest worldwide longitudinal analysis of the political, social, and economic determinants of universal healthcare in 196 countries (published in Health Policy). She has further authored several high=level reports, including Development Aid Flows for Chronic Diseases for the Center for Global Development, a background paper on the political economy of universal healthcare for WHO and a leading World Economic Forum/Harvard report on the global economic burden of chronic diseases. This work was featured at the UN High Level Summit on NCD's in 2011. During this interview we talk about manifesting the things you want to happen in your life. We talk about how the pandemic impacted the opening of Health Finance Institute's first office.  Andrea also talks about her passion for dance and what it has given to her personally. This guest has an incredible spirit and truly is working on changemaking in all of the work that she is doing every single day.  Listen in to hear the footprint that Andrea is creating now that she wants to leave behind. Next week my guest is Fran Hauser. Fran is a best-selling author of The Myth of the Nice Girl: Achieving a Career you Love Without Becoming a Person You Hate and her new book, Embrace the Work, Love Your Career. Fran has also invested in over 30 female-founded companies. Full episode launches November 2, 2022.  Today Is the DayWebsite: https://todayisthedayliveit.comFacebook: https://www.facebook.com/todayistheday/Instagram: https://www.instagram.com/todayisthedayThe Zzak G. Applaud Our Kids FoundationWebsite: www.applaudourkids.orgFacebook: https://www.facebook.com/applaudourkidsInstagram: https://www.instagram.com/applaudourkidsSign-up for our mailing list, schedule a conversation with Jodi or ask a Changemaker a question: jodi@todayisthedayliveit.comHave a great week everyone!

Welcome to this episode! Join editor & host, Ryan Smith, as he interviews Brianna Heath, North Central District Vice President for Programs, about her journey in Kappa Kappa Psi and goals for her District. Transcription coming soon. Questions, Comments, Suggestions: smity@kkpsi.org

Chronic kidney disease is an NCD that we've struggled to tackle for decades. In fact, the burden of chronic kidney disease continues to rise - and thus the number of people who progress to end-stage renal disease, a point where they need to be on dialysis or receive a kidney transplant. On this episode of NCD Chronicles, we hear from Siva Kumar Raghavan, who is now living with end-stage renal disease, about his journey from being diagnosed with chronic kidney disease, to receiving a kidney transplant, and having to return to dialysis when his transplant failed. We also hear from Dr Rosnawati Yahya, consultant nephrologist from Hospital Kuala Lumpur about the challenges that patients face in accessing dialysis and finding a kidney donor.NCD Chronicles is a series about people living with NCDs, going beyond the diagnosis to explore their personal experiences, their challenges, as well as the impact of their health condition on their loved ones. These stories reveal the importance of understanding the unique struggles and needs of the individuals behind the disease, in our response to the NCD epidemic.

Welcome to this episode! Join editor & host, Ryan Smith, as he interviews Jayar Brenner, North Central District Vice President for Communication, about his journey in Kappa Kappa Psi and goals for his District. Transcription is located here. Questions, Comments, Suggestions: smity@kkpsi.org

Welcome to this episode! Join editor & host, Ryan Smith, as he interviews Lauren Smith, North Central District President, about her journey in Kappa Kappa Psi and goals for her District. Transcription is located here. Questions, Comments, Suggestions: smity@kkpsi.org

Could Medicare finally fund seat elevation systems for power wheelchairs? For the first time ever, it's looking possible. Medicare is opening its NCD up to review, which would mean a public comment period, and setting the stage for that was a virtual roundtable hosted by the National Council on Disability regarding funding the systems. Seth Johnson, the senior vice president of Government Relations for Pride Mobility/Quantum Rehab, joined the podcast to give us an insider's view of the roundtable meeting.

This is an “ask me anything” (AMA) episode, which means a world-class expert and past podcast guest comes on the podcast to answer questions submitted by you, our podcast listeners. Stephan Guyenet spent 12 years in academia studying neurodegenerative disease and obesity neuroscience. He was a postdoctoral fellow at the Univeristy of Washington, studying the neuroscience of obesity and eating behavior. Previous to that he completed a PhD in neuroscience. Stephan is the author of the popular and well-received book ‘The Hungry Brain‘, which lays out the science behind the brain's role in obesity. To subscribe to Premium (and get the full episode) go here. Questions Answered In Full Episode “When someone undergoes liposuction or other surgery that removes adipose tissue, is there a sudden reduction in leptin levels? While this may reduce leptin resistance, could the drop in leptin lead to increased hunger over time?” “What is the current research around how chronic energy restriction (or following crash diets) affects appetite hormones and/ or appetite regulation long term? Is there a physiological mechanism influencing overeating attributable to appetite dysregulation caused by chronic dieting? I ask as this is something I am often tackling in my nutrition consultancy but research in biochemical and physiological mechanisms seems lacking.” “Can you talk about the conditions of anorexia and morbid obesity and how they essentially defy the rules of metabolic compensation? In other words- I understand anorexia to be a mental health condition where the individual starves themselves with a purpose to control weight. And morbid obesity being excessive consumption despite over fatness, etc. If the body has these numerous mechanisms by which calorie restriction or calorie over- consumption results in these compensatory processes-driving us to eat more/less slow us down/speed us up, and many more; do these individuals not “hear” these signals or are they just adept at ignoring them or is it that their bodies have lost the ability to compensate for their under or over consumption? Additionally, can anyone become anorexic or morbidly obese? Or is it merely genetics?” “Why do some SDRIs (serotonin–dopamine reuptake inhibitors) and serotonin precursors reduce hunger/appetite? E.g. 5-HTP and Wellbutrin (Bupropion)” “Question about the ideal weight program: As an iOS developer, my instinct is to assume determinism and quantifiability of the entire universe. I believe this to be fundamentally true. But what is hypothetically possible differs from what we can realistically know. I worry that attempts like yours to quantify some seemingly qualitative measures are doomed. I have similar concerns about happiness research. How do you reassure yourself you can really construct an algorithm that deciphers the “ideal weight program” for any given user – do you rely on averages?” a. Quick explanation of the ideal weight program “In 2018 a poster was presented at the annual meeting of the Society for Neuroscience titled ‘The human brain microbiome; there are bacteria in our brains!' which showed bacteria apparently penetrating and inhabiting the cells of healthy human brains. While the work was preliminary, have you heard of any further work in this area? What is your opinion on the possibility that, if bacteria do inhabit the brain, they could play a part in appetite regulation and/or obesity similar to how the gut microbiome can affect our health?” “It seems like there are significant differences in policies put forth between researchers from biomedical backgrounds and ones from public health policy backgrounds. Dr [David] Allison touched on this during recent interviews, noting that there is very little evidence regarding the efficacy of upstream obesity prevention interventions, such community gardens, combatting food deserts, nutrition education, and cooking classes. On the other hand, governments are increasingly turning to such interventions, as well as policies such as front of pack labelling (Canada, 2022), nutrition facts tables, calorie labelling on menus, as well as the aforementioned ones. Given your research on determinants of health and obesity, what are some of the most promising interventions to prevent NCD morbidity, as well as stones unturned in public health policy? Would you agree with individuals such as Dr Allison that in our current environment, the only efficacious interventions are drugs and bariatric surgery?” Question based on your debate on JRE with Gary Taubes: “Would the insulinogenic effect of protein, specifically something like whey protein which causes an insulin response, be something that should automatically refute Taubes arguments about insulins inherent role in increasing adiposity? Second, would overeating on any macronutrient increase insulin simply because you are eating more food (i.e. hypercaloric)?” “Are there best practices for the maximum duration someone should spend in fat loss (or weight gain) phases? Or perhaps an optimal ratio of fat loss phase duration to “maintenance” phase duration? For example, should fat loss phases be for a maximum of 12 weeks followed by maintenance of at least equal duration before resuming a fat loss phase? “I'm a naturally skinny guy who helps other naturally skinny guys bulk up. I think it largely comes down to a blunted pleasure response to food, smaller stomachs, and/or higher NEAT. A lot of us seem to be taller and more thinly built, too. But why do you think things are things so different for us? Why is it so hard to gain weight? And what can we do about it?” To subscribe to Premium (and get the full episode) go here.

As the Russian invasion of Ukraine continues, living under the uncertainty has become the new normal for thousands of patients with diabetes who are dependant on insulin. Supporting patients with non-communicable disease is the reality of all disaster situations now, and that added layer of complexity makes coordinating responses even harder. In this podcast, we'll hear how people with diabetes are being supported in Ukraine, and what is being done to improve things, despite the continued fighting. Our guests; Iryna Vlasenko, Vice President of the International Diabetes Federation Slim Slama, unit head for NCD management at the WHO Yaroslav Diakunchak, family physician in Brovary, Kyiv.

Tune into the second episode in the Avalere Health Essential Voice podcast series focused on the how CMS and Medicare coverage decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs)that have coverage with evidence development (CED) requirements, how FDA and CMS's evidence questions can be complimentary, and the ways in which manufacturer evidence generation plans can address those goals, using the NCD on monoclonal antibodies for Alzheimer's disease as an example.

Tune into the first episode in the Avalere Health Essential Voice podcast series focused on how CMS and Medicare coverage decisions define patient access. In this segment, our Market Access experts discuss national coverage determinations (NCDs), specifically those with coverage with evidence development (CED), their impacts to patient access, and considerations for life sciences companies.

Schools can be an important focus for screening of children for epilepsy, as well as educational efforts to address basic knowledge, stigma, and misconceptions associated with epilepsy. Schools also are an appropriate and necessary place to provide seizure first aid to affected students, teachers, and staff, as well as rescue medications when needed.There is strong stigma around epilepsy in India;  parents may deny that a child has epilepsy, even if a community health worker has observed the child having seizures. And teachers and school administrators can be reluctant to allow children with epilepsy to attend school. This, combined with the social stigma of epilepsy and possible learning and cognitive issues, can lead to academic underachievement, lost opportunities, and poor quality of life into and throughout adulthood.To better understand the epilepsy treatment gap in children, as well as to begin addressing the gap on a school-based level, Dr. Sulena Singh and colleagues developed a three-year project of surveys and training activities. Dr. Sulena is in the Division of Neurology, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India.The project is supported by an ad hoc grant (No.5/4-5/189/Neuro / 2019-NCD-1) from the Indian Council of Medical Research, New Delhi.Read more about the project on the ILAE website.This episode was reported, edited and produced by Nancy Volkers.Contact ILAE with feedback or episode ideas at podcast@ilae.orgSharp Waves content is meant for informational purposes only and not as medical or clinical advice. The International League Against Epilepsy is the world's preeminent association of health professionals and scientists working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Twitter, and Instagram. Support the showSharp Waves episodes are meant for informational purposes only, and not as clinical or medical advice.The International League Against Epilepsy is the world's preeminent association of health professionals and scientists, working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Twitter, and Instagram.

Welcome to this bonus episode! Join editor & host, Ryan Smith, as he interviews Tyler Stump, North Central District President, about the upcoming District Conventions. Transcription coming soon. Questions, Comments, Suggestions: smity@kkpsi.org

The NCD is back to wrap up this case and deliver it to the Commissioner in time for Christmas. What lies in wait for Peppermint Schnapps? What's hidden in the professor's basement? How does Mrs. Claus bake such delicious cookies?! Tune in to see if our heroes can save Christmas — and the world!Starring Sky Swanson (Christmas Keeper), Casey Reardon (JEREME), Rachel Kordell (Pea Honeypot), Jonas Tintenseher (Phoebe Morganstern), Andrew Frost (Major Eilert von Zinn), and Seth Coveyou (Peppermint Schnapps)."Dance of the Sugar Plum Fairies", "What Child Is This", and "Krampus Workshop" by Kevin MacLeod (incompetech.com, CC BY 3.0/4.0).